Efficacy and tolerability of a fixed-dose moxifloxacin &ndash; dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial

Efficacy and tolerability of a fixed-dose moxifloxacin &ndash; dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial

Mauro Campos, Mariana &Aacute;vila, Anelise Wallau, Cristina Muccioli, Ana Luisa H&ouml;fling-Lima, Rubens Belfort JrDepartment of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de S&atilde;o Paulo, S&atilde;o Paulo, BrazilPurpose: To compare the eff...

Full description

Bibliographic Details
Main Authors:	Mauro Campos, Mariana &Aacute;vila, Anelise Wallau, Cristina Muccioli, Ana Luisa H&ouml;fling-Lima, Rubens Belfort Jr
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-06-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/efficacy-and-tolerability-of-a-fixed-dose-moxifloxacin-ndash-dexametha-a1788

Similar Items

Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK
by: Mauro Campos, et al.
Published: (2011-02-01)

Efficacy and Tolerability of a Combined Moxifloxacin/Dexamethasone Formulation for Topical Prophylaxis in Phacoemulsification: An Open-Label Single-Arm Clinical Trial
by: Cesar Ramon G. Espiritu, et al.
Published: (2011-01-01)

Cohort Study of Intracameral Moxifloxacin in Postoperative Endophthalmitis Prophylaxis
by: Virgilio Galvis, et al.
Published: (2014-01-01)

Cohort Study of Intracameral Moxifloxacin in Postoperative Endophthalmitis Prophylaxis
by: Virgilio Galvis, et al.
Published: (2014-01-01)

Choice of baseline in a multiple-dose thorough QT study (TQTS) &ndash; effect on analysis of moxifloxacin-induced QTc prolongation
by: B Tyl,&nbsp;S Azzam,&nbsp;E Reinbolt, et al.
Published: (2009-12-01)

Corneal deposits following topical moxifloxacin use
by: Abdulaziz A. Alshamrani, et al.
Published: (2019-04-01)

Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification
by: Ibraim Viana Vieira, et al.

Acute iris depigmentation following systemic moxifloxacin
by: Heloisa Moraes do Nascimento, et al.
Published: (2013-07-01)

Simultaneous determination of dexamethasone and moxifloxacin in pharmaceutical formulations using stability indicating HPLC method
by: Syed Naeem Razzaq, et al.
Published: (2017-03-01)

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
by: Lisa Trieu, et al.
Published: (2015-03-01)

Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India
by: Varsha M Rathi, et al.
Published: (2020-01-01)

The effect of topical ocular moxifloxacin on conjunctival and nasal mucosal flora
by: Ali Riza Cenk Celebi, et al.
Published: (2021-07-01)

Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin
by: Koji Sugioka, et al.
Published: (2009-10-01)

Neuropsychology of eating disorders: 1995–2012
by: J&aacute;uregui-Lobera I
Published: (2013-03-01)

A biodegradable polymeric system for peptide–protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process
by: Alcal&aacute;-Alcal&aacute; S, et al.
Published: (2013-06-01)

Postoperative endophthalmitis with and without intracameral moxifloxacin prophylaxis in a high volume surgery setting
by: Subash Bhatta, et al.
Published: (2021-07-01)

Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood–brain barrier permeability
by: Ol&aacute;h G, et al.
Published: (2013-09-01)

Two-step LASIK after penetrating keratoplasty
by: Aris&nbsp;N Kollias, et al.
Published: (2009-10-01)

Participation in physical and social activities among home-dwelling persons with dementia – experiences of next of kin
by: S&ouml;derhamn U, et al.
Published: (2013-06-01)

Topical moxifloxacin-induced toxic epidermal necrolysis and Stevens-Johnson syndrome
by: A Dhavaleshwar, et al.
Published: (2019-01-01)

Volunteering in dementia care &ndash; a Norwegian phenomenological study
by: S&ouml;derhamn U, et al.
Published: (2012-02-01)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
by: Jane S Myung, et al.
Published: (2010-12-01)

Dabigatran for prophylaxis of thromboembolic events in patients with atrial fibrillation
by: Ehrlich JR, et al.
Published: (2012-01-01)

Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration
by: Gail Torkildsen, et al.
Published: (2010-04-01)

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein&ndash;Barr virus disease
by: Heather&nbsp;E Vezina, et al.
Published: (2009-12-01)

Disease-modifying therapies in relapsing&ndash;remitting multiple sclerosis
by: Fabricio Gonz&aacute;lez-Andrade, et al.
Published: (2010-07-01)

Topical application of 0.05% cyclosporine A as an adjunct to LASIK
by: E. V. Kudryashova, et al.
Published: (2015-12-01)

Topical Steroids for Prevention of Diffuse Lamellar Keratitis Following LASIK
by: Farid Karimian, et al.
Published: (2008-11-01)

Beals&ndash;Hecht syndrome and choroidal neovascularization
by: Roberto Gallego-Pinazo, et al.
Published: (2010-07-01)

Breakthrough cancer pain &ndash; still a challenge
by: Ma&ntilde;as A, et al.
Published: (2012-11-01)

Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
by: Rafael Zaragoza, et al.
Published: (2008-11-01)

Keratitis by Scopulariopsis brevicaulis Fungus After LASIK – A Case Report
by: Baptista PM, et al.
Published: (2021-02-01)

Netilmicin/dexamethasone fixed combination in the treatment of conjunctival inflammation
by: Faraldi F, et al.
Published: (2013-06-01)

Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness
by: Linertová R, et al.
Published: (2014-08-01)

Moxifloxacin: safety profile
by: A. I. Sinopalnikov
Published: (2013-12-01)

Moxifloxacin-warfarin interaction
by: Yan Ji, et al.
Published: (2012-01-01)

Thought&ndash;shape fusion and body image in eating disorders
by: J&aacute;uregui-Lobera I, et al.
Published: (2012-10-01)

Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone
by: Yuslay Fernández Zamora, et al.
Published: (2015-08-01)

A Case Report of Severe Corneal Toxicity following 0.5% Topical Moxifloxacin Use
by: A.P. Vignesh, et al.
Published: (2015-02-01)

Computer applications for prediction of protein&ndash;protein interactions and rational drug design
by: Sol&egrave;ne Grosdidier, et al.
Published: (2009-11-01)